| 14th Feb 2018 9:00 am |
RNS |
GSK submits landmark IMPACT data - Trelegy Ellipta |
| 13th Feb 2018 4:44 pm |
RNS |
Director/PDMR Shareholding |
| 12th Feb 2018 2:43 pm |
RNS |
Director/PDMR Shareholding |
| 12th Feb 2018 12:47 pm |
RNS |
Director/PDMR Shareholding |
| 8th Feb 2018 9:31 am |
RNS |
ViiV Healthcare launches new two-drug HIV study |
| 8th Feb 2018 7:00 am |
RNS |
ViiV files patent infringement litigation |
| 7th Feb 2018 1:19 pm |
RNS |
Director/PDMR Shareholding |
| 7th Feb 2018 12:01 pm |
RNS |
Final Results |
| 7th Feb 2018 9:04 am |
RNS |
GSK's Bexsero FDA Breakthrough Therapy Designation |
| 1st Feb 2018 11:52 am |
RNS |
Total Voting Rights |
| 26th Jan 2018 12:30 pm |
RNS |
GSK's Shingrix - positive CHMP opinion in Europe |
| 26th Jan 2018 9:00 am |
RNS |
GSK's Relvar Ellipta - positive CHMP opinion |
| 23rd Jan 2018 3:22 pm |
RNS |
Director/PDMR Shareholding |
| 19th Jan 2018 5:19 pm |
RNS |
Director/PDMR Shareholding |
| 19th Jan 2018 5:17 pm |
RNS |
Director/PDMR Shareholding |
| 16th Jan 2018 5:48 pm |
RNS |
Director/PDMR Shareholding |
| 15th Jan 2018 5:59 pm |
RNS |
Director/PDMR Shareholding |
| 15th Jan 2018 5:54 pm |
RNS |
Director/PDMR Shareholding |
| 15th Jan 2018 5:34 pm |
RNS |
Director/PDMR Shareholding |
| 15th Jan 2018 9:18 am |
RNS |
Director/PDMR Shareholding |
| 15th Jan 2018 9:04 am |
RNS |
Director/PDMR Shareholding |
| 11th Jan 2018 3:33 pm |
RNS |
Director/PDMR Shareholding |
| 2nd Jan 2018 2:00 pm |
RNS |
Director Shareholding |
| 2nd Jan 2018 1:54 pm |
RNS |
Total Voting Rights |
| 21st Dec 2017 9:02 am |
RNS |
FDA approval - on ICS/LABA combinations in asthma |
| 18th Dec 2017 4:21 pm |
RNS |
Director/PDMR Shareholding |
| 15th Dec 2017 7:00 am |
RNS |
Transfer of Shares out of Treasury |
| 12th Dec 2017 4:50 pm |
RNS |
Director/PDMR Shareholding |
| 12th Dec 2017 4:16 pm |
RNS |
GSK gains US approval for Nucala to treat EGPA |
| 12th Dec 2017 7:00 am |
RNS |
Promising data for GSK2857916 at ASH meeting |
| 6th Dec 2017 7:00 am |
RNS |
New data - Shingrix in immune-compromised patients |
| 1st Dec 2017 1:47 pm |
RNS |
Director/PDMR Shareholding |
| 1st Dec 2017 1:44 pm |
RNS |
Director/PDMR Shareholding |
| 1st Dec 2017 1:37 pm |
RNS |
Total Voting Rights |
| 30th Nov 2017 7:00 am |
RNS |
ViiV starts Phase 3 HIV prevention study in women |
| 27th Nov 2017 2:03 pm |
RNS |
ViiV starts Phase 3 longacting HIV treatment study |
| 23rd Nov 2017 7:00 am |
RNS |
GSK submit IMPACT data to support Trelegy Ellipta |
| 22nd Nov 2017 7:00 am |
RNS |
ViiV Juluca approved in US as first 2-drug regimen |
| 21st Nov 2017 2:21 pm |
RNS |
GSK publishes 2018 dividend dates |
| 16th Nov 2017 7:00 am |
RNS |
Trelegy Ellipta EU approval for treatment of COPD |
